Muthalagu Ramanathan

2.3k citations

53 papers · 390 indexed · h-index 11

Hematology top 5%
- Hematopoietic Stem Cell Transplantation 16
- Acute Myeloid Leukemia Research 13
- Multiple Myeloma Research and Treatments 4
Immunology
- Immune Cell Function and Interaction 8
Medical Terminology
Genetics
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
Oncology
- CAR-T cell therapy research 3
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 4

Co-authors: Jan Černý Eric S. Winer Gerald J. Elfenbein Gerald A. Colvin Peter J. Quesenberry Loren D. Fast David Berz Rajneesh Nath
Cited by: Hematology Immunology Medical Terminology
Journals: Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (3 papers)Blood (11 papers)
Partner nations: United States Netherlands India

In The Last Decade

Muthalagu Ramanathan

48 papers receiving 377 citations

Peers

Countries citing papers authored by Muthalagu Ramanathan

Since Specialization

Citations

This map shows the geographic impact of Muthalagu Ramanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muthalagu Ramanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muthalagu Ramanathan more than expected).

Fields of papers citing papers by Muthalagu Ramanathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muthalagu Ramanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muthalagu Ramanathan. The network helps show where Muthalagu Ramanathan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Muthalagu Ramanathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Muthalagu Ramanathan Line = papers co-authored together Muthalagu Ramanathan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An open-label, multi-center Phase 2 study to assess the safety and efficacy of burixafor (GPC-100) and propranolol with G-CSF for the mobilization of hematopoietic progenitor cells in patients with multiple myeloma Blood ·Yosra Aljawai,Ah‐Reum Jeong,Muthalagu Ramanathan,Gunjan L. Shah,Hyung C. Suh,John Hiemenz,Jonathan D. Licht,William Clark,Luke P. Akard,Ann Woolfrey,Devki Sukhtankar,Pina M. Cardarelli,Niña G. Caculitan,Jack Khouri	2025	0
2	Outcomes of adults older than 70 years of age undergoing allogeneic stem cell transplantation Leukemia Research ·Ishan Bhatia,Shyam A. Patel,Laurie Pearson,K. T. Parthiban,Sakiko Suzuki,Poorva Bindal,Andrew Gillis-Smith,Muthalagu Ramanathan,Jonathan M. Gerber,Rajneesh Nath,Jan Černý	2025	0
3	Natural history of clonal haematopoiesis seen in real‐world haematology settings British Journal of Haematology ·Shyam A. Patel,William K Gerber,Rena Zheng,Shrinkhala Khanna,Lloyd Hutchinson,Gregory A. Abel,Jan Černý,Brandon A. DaSilva,Tian Yi Zhang,Muthalagu Ramanathan,Salwa Khedr,William Selove,Bruce A. Woda,Patricia M. Miron,Anne W. Higgins,Jonathan M. Gerber	2024	8
4	Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions SHILAP Revista de lepidopterología ·Shyam A. Patel,Jan Černý,William K Gerber,Muthalagu Ramanathan,Asiri Ediriwickrema,Benjamin Tanenbaum,Lloyd Hutchinson,Xiuling Meng,Julie Flahive,Bruce Barton,Andrew Gillis-Smith,Sakiko Suzuki,Salwa Khedr,William Selove,Anne W. Higgins,Patricia M. Miron,Karl Simin,Bruce A. Woda,Jonathan M. Gerber	2023	18
5	The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR study Bone Marrow Transplantation ·Muthalagu Ramanathan,Soyoung Kim,Naya He,Min Chen,Peiman Hematti,Muhammad Bilal Abid,Seth J. Rotz,Kirsten M. Williams,Hillard M. Lazarus,Baldeep Wirk,Dwight E. Yin,Christopher G. Kanakry,Miguel‐Angel Perales,Roy F. Chemaly,Christopher E. Dandoy,Marcie Riches,Celalettin Üstün	2022	8
6	Impact of Covid-19 on Cancer Patients: A Single Center Experience and Comparison to National Data The Journal of the American Medical Association (JAMA) Network (American Medical Association) ·D. Dalela,Tzafra Tessier,Muthalagu Ramanathan	2021	1
7	Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia SHILAP Revista de lepidopterología ·William Selove,Lloyd Hutchinson,Vladislav Makarenko,Xiuling Meng,Keith Tomaszewicz,Muthalagu Ramanathan,Jan Černý,Rajneesh Nath,Bowen Chen,Bruce A. Woda,Jacob R. Bledsoe	2021	4
8	Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses Blood Cells Molecules and Diseases ·Xin Wang,Bennett E Vogt,Lindsey Shanahan,Ahmad Daniyal Siddiqui,Subramony Subramonia-Iyer,Saleem Khanani,Josef Bednařík,Kriti Mittal,Muthalagu Ramanathan,Jonathan M. Gerber,Jan Černý	2020	2
9	Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant Biology of Blood and Marrow Transplantation ·Christopher Strouse,Ying Zhang,Mei‐Jie Zhang,Alyssa DiGilio,Marcelo C. Pasquini,Mary M. Horowitz,Stephanie J. Lee,Vincent T. Ho,Muthalagu Ramanathan,Wichai Chinratanalab,Alison W. Loren,Linda J. Burns,Andrew Artz,Kathleen F. Villa,Wael Saber	2018	47
10	Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns Drugs & Aging ·Zeina Al‐Mansour,Muthalagu Ramanathan,Jan Černý	2018	5
11	Stratification of Allogeneic Hematopoietic Cell Transplant Patients by Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score Biology of Blood and Marrow Transplantation ·Christopher Strouse,Ying Zhang,Mei‐Jie Zhang,Alyssa DiGilio,Stephanie J. Lee,Muthalagu Ramanathan,Wichai Chinratanalab,Alison W. Loren,Linda J. Burns,Andrew Artz,Kathleen F. Villa,Wael Saber	2017	2
12	Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation Leukemia Research Reports ·Jan Černý,Katherine Devitt,Hongbo Yu,Muthalagu Ramanathan,Bruce A. Woda,Rajneesh Nath	2014	2
13	MYC Protein Expression Is Detected in Plasma Cell Myeloma but Not in Monoclonal Gammopathy of Undetermined Significance (MGUS) The American Journal of Surgical Pathology ·Ruobing Xiao,Jan Černý,Katherine Devitt,Karen Dresser,Rajneesh Nath,Muthalagu Ramanathan,Scott J. Rodig,Benjamin J. Chen,Bruce A. Woda,Hongbo Yu	2014	21
14	Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis Blood ·Muthalagu Ramanathan,Pierre Teira,Minoo Battiwalla,A. John Barrett,Caroline A. Lindemans,Jeffery J. Auletta,Kwang Woo Ahn,Min Chen,Marcie Riches,Michael Boeckh	2014	6
15	Hemophagocytic lymphohistiocytosis secondary to T-cell/histiocyte-rich large B-cell lymphoma Leukemia Research Reports ·Katherine Devitt,Jan Černý,Bradley Switzer,Muthalagu Ramanathan,Rajneesh Nath,Hongbo Yu,Bruce A. Woda,Benjamin J. Chen	2014	14
16	Optimizing Lentiviral Transduction of Human Natural Killer Cells Blood ·Su Su,Dawn M Betters,Muthalagu Ramanathan,Keyvan Keyvanfar,Aleah Smith,Xingmin Feng,Elissa Furutani,Mattias Carlsten,Andreas Lundqvist,Richard Childs	2011	4
17	Nonengraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism Biology of Blood and Marrow Transplantation ·Gerald A. Colvin,David Berz,Muthalagu Ramanathan,Eric S. Winer,Loren D. Fast,Gerald J. Elfenbein,Peter J. Quesenberry	2009	56
18	Diagnosis of anomalous origin of left coronary artery from pulmonary artery in an adult by 64-slice CT angiography. PubMed ·A. Krishnamoorthy,G Venkatesh,M Vijayakumar,K Preeetham,Muthalagu Ramanathan	2009	1
19	Natural Killer (NK) Cells Are Resistant to the Apoptotic Effects of Corticosteroids Compared to T Cells: Implications for Adoptive NK Cell Therapy Following Allogeneic HCT Biology of Blood and Marrow Transplantation ·Muthalagu Ramanathan,Andreas Lundqvist,Hiroyuki Yokoyama,Aaron T. Smith,R. Childs	2009	2
20	Abdominal tuberculosis: a presumptive diagnosis. PubMed ·Muthalagu Ramanathan,S Wahinuddin,E Safari,S P Sellaiah	1997	3

About Muthalagu Ramanathan

Muthalagu Ramanathan is a scholar working on Hematology, Genetics and Oncology, having authored 53 papers that have together received 390 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (8 papers), Multiple Myeloma Research and Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (243 citations), Immunology (102 citations) and Medical Terminology (1 citation). Muthalagu Ramanathan has collaborated with scholars based in United States, Netherlands and India. Frequent co-authors include Jan Černý, Eric S. Winer, Gerald J. Elfenbein, Gerald A. Colvin, Peter J. Quesenberry, Loren D. Fast, David Berz, Rajneesh Nath, Zeina Al‐Mansour and Bruce A. Woda. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact